Genedrive (D6M) Stock Statistics & Valuation Metrics
Total Valuation
Genedrive has a market cap or net worth of EUR 18.76M. The enterprise value is EUR 7.43M.
- Market Cap
- EUR 18.76M
- Enterprise Value
- EUR 7.43M
Share Statistics
Genedrive has 1,605,568,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,605,568,200
- Owned by Insiders
- 1.02%
- Owned by Institutions
- ―
Financial Efficiency
Genedrive’s return on equity (ROE) is -3.64 and return on invested capital (ROIC) is -360.69%.
- Return on Equity (ROE)
- -3.64
- Return on Assets (ROA)
- -1.86
- Return on Invested Capital (ROIC)
- -360.69%
- Return on Capital Employed (ROCE)
- -3.74
- Revenue Per Employee
- 17.77K
- Profits Per Employee
- -121.65K
- Employee Count
- 43
- Asset Turnover
- 0.27
- Inventory Turnover
- 0.16
Valuation Ratios
The current PE Ratio of Genedrive is -0.89. Genedrive’s PEG ratio is -0.01.
- PE Ratio
- -0.89
- PS Ratio
- 14.67
- PB Ratio
- -19.88
- Price to FCF
- -4.02
- Price to Operating Cash Flow
- -2.12
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Genedrive had revenue of 764.00K and earned -5.23M in profits. Earnings per share was -0.01.
- Revenue
- 764.00K
- Gross Profit
- 764.00K
- Operating Income
- -5.38M
- Pretax Income
- -5.43M
- Net Income
- -5.23M
- EBITDA
- -5.36M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -3.89M and capital expenditures -10,000, giving a free cash flow of -3.90M billion.
- Operating Cash Flow
- -3.89M
- Free Cash Flow
- -3.90M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Genedrive pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -24.90%
- Earnings Yield
- -64.77%
Stock Price Statistics
- Beta
- 5.69
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 43.02
- Average Volume (3m)
- 5,200
Important Dates
Genedrive upcoming earnings date is Nov 24, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Mar 30, 2026
- Next Earnings Date
- Nov 24, 2026
- Ex-Dividend Date
- ―
Financial Position
Genedrive as a current ratio of 1.95, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.95
- Quick Ratio
- 1.64
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.22
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Genedrive has paid -195.00K in taxes.
- Income Tax
- -195.00K
- Effective Tax Rate
- 0.04
Enterprise Valuation
Genedrive EV to EBITDA ratio is -2.83, with an EV/FCF ratio of -4.04.
- EV to Sales
- 14.78
- EV to EBITDA
- -2.83
- EV to Free Cash Flow
- -4.04
- EV to Operating Cash Flow
- -4.06
Balance Sheet
Genedrive has EUR 387.00K in cash and marketable securities with EUR 500.00K in debt, giving a net cash position of -EUR 113.00K billion.
- Cash & Marketable Securities
- EUR 387.00K
- Total Debt
- EUR 500.00K
- Net Cash
- -EUR 113.00K
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 84.16%, with operating margin of -518.84%, and net profit margin of -500.75%.
- Gross Margin
- 84.16%
- Operating Margin
- -518.84%
- Pretax Margin
- -516.68%
- Net Profit Margin
- -500.75%
- EBITDA Margin
- -522.68%
- EBIT Margin
- -526.99%
Analyst Forecast
The average price target for Genedrive is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 63.61%
- EPS Growth Forecast
- 74.73%
